ArticleJournal for immunotherapy of cancer2026

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.

Eileen M O'Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.